Immunotherapy and immunoprophylaxis of leprosy

Indian Journal of Leprosy

Volumn 72, Issue 1, 2000, Pages 21-32

  Convit, J ^a   Ulrich, M ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; THALIDOMIDE;

CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; ERYTHEMA NODOSUM LEPROSUM; EUROPE; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; INCIDENCE; LEPROSY; MYCOBACTERIUM LEPRAE; TREATMENT OUTCOME; TUBERCULOSIS; VACCINATION; VENEZUELA; WORLD HEALTH ORGANIZATION;

BCG VACCINE; CLINICAL TRIALS; HUMANS; IMMUNOTHERAPY; LEPROSY; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE;

EID: 0033902673     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Cultivation of Mycobacterium leprae; A new approach
2. A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar
3. Immunotherapeutic potential of ICRC vaccine: A case control study
4. Reversal reaction in lepromatous leprosy patients induced by a vaccine containing killed ICRC bacilli - A report of 5 cases
5. Immunoreactive antigens of a candidate leprosy vaccine
6. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG
7. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts
8. A test for the determination of competency in clearing bacilli in leprosy patients
9. Elimination of Mycobacterium leprae subsequent to local in-vivo activation of macrophages in lepromatous leprosy by other mycobacteria
10. Immunoprophylaxis trial with combined Mycobacterium leprae/BCG vaccine against leprosy: Preliminary results
11. BCG vaccination protects against leprosy in Venezuela. A case-control study
12. The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis
13. Leprosy transmission and mucosal immunity: Towards eradication?
14. Anti-leprosy potential of ICRC vaccine: A study in patients and healthy volunteers
15. Leprosy beyond the year 2000
16. Comparative leprosy vaccine trial in South India
17. Analysis of vaccines prepared from armadillo-derived M. leprae; Results of an inter-laboratory study coordinated by the World Health Organization
18. Relapse after long-term follow-up of multibacillary patients treated by WHO multidrug regimen
19. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
20. Immunotherapy of leprosy
21. Attempts to establish the armadillo (Dasypus novemcinctus Linn) as a model for the study of leprosy. 1. Report of lepromatoid leprosy in the experimentally infected armadillo
22. [The protective efficacy of BCG against leprosy in Sao Paulo, Brazil.]
23. BCG vaccination of children against leprosy: Fourteen year findings of the trial in Burma
24. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose Convit vaccine along with multidrug therapy (Calcutta trial)
25. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG
26. India approves leprosy vaccine
27. Restoration of proliferative response to M. leprae antigens in lepromatous T-cells against candidate antileprosy vaccines
28. Local and systemic effects of low doses of recombinant interferon-γ, after intradermal injection in patients with lepromatous leprosy
29. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in Western Kenya
30. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
31. Effect of rhuIFN-γ treatment in multibacillary leprosy patients
32. Leprosy elimination - Urgent action required
33. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: Report on a hospital-based clinical trial with the candidate antileprosy vaccine
34. BCG vaccination of children against leprosy in Uganda
35. Does bacillus Calmette-Guerin scar size have implications for protection against tuberculosis or leprosy?
36. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients
37. Report of a special meeting of the leprosy elimination advisory group (LEAG) with potential partners
38. Addition of immunotherapy with Mycobacterium w vaccine to multi-drug therapy benefits multibacillary leprosy patients
39. Protective effect of bacillus Calmette Guerin (BCG) against leprosy: A population-based case-control study in Nagpur, India